Enzo Biochem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

ENZ 6.97 +0.27 (4.03%)
price chart
Option Market: Enzo Biochem Inc (NYSE:ENZ) Risk Hits An Elevated Level
This is a proprietary risk rating for the next 30-days built by Capital Market Laboratories (CMLviz) based on a large number of interactions of data points, many of which come directly from the option market for Enzo Biochem Inc (NYSE:ENZ) . The risk ...
Enzo Biochem, Inc. (NYSE:ENZ)'s Basic Consolidated EPS Came In At $-0.0504  Equities Focus
Enzo Biochem Inc Stock Momentum Hits Strength
This is a momentum stock rating analysis for Enzo Biochem Inc (NYSE:ENZ) . The company has a four bull momentum rating which indicates some strength.
Enzo Biochem Inc. (NYSE:ENZ) Stock Momentum Hits Strength
This is a momentum stock rating analysis for Enzo Biochem Inc. (NYSE:ENZ) . The company has a four bull momentum rating which indicates some strength.
Lone Star Value Issues Open Letter to Shareholders of Enzo Biochem, Inc.
Lone Star Value Management, LLC together with its affiliates and the other participants in its solicitation, (collectively, "Lone Star Value", "LSV", "us", or "we"), owns approximately 600,000 shares of Enzo Biochem, Inc. ("Enzo" or the "Company"). We ...
Form 8-K ENZO BIOCHEM INC For: Dec 21  StreetInsider.com
Enzo Biochem Issues Open Letter to Shareholders  Business Wire (press release)
Shares Trending Upward for the Week: Enzo Biochem Inc. (NYSE:ENZ)
Investors Enzo Biochem Inc. (NYSE:ENZ) are heading into the weekend on a positive note as the stock provided some gains this week moving 6.57% over the past 5 trading days.
Enzo Biochem Incorporated (NYSE:ENZ) Shorted Shares Decreased By 16.29%  Consumer Eagle
Enzo Biochem, Inc. (NYSE:ENZ) Given Average Rating of "Strong Buy" by Analysts
Enzo Biochem logo Shares of Enzo Biochem, Inc. (NYSE:ENZ) have been given a consensus broker rating score of 1.00 (Strong Buy) from the two analysts that cover the company, Zacks Investment Research reports.
Enzo Biochem Announces New York State Approval of New Women's Test Based on ...
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today announced that the New York State Department of Health has granted conditional approval for use of Enzo Clinical Labs' AmpiProbe Candidiasis™ assay, the Company's second test ...
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) Hits New 52-week High During July 18 ...
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) hit a new 52-week high yesterday, reaching a peak of $6.85 after opening at $6.53 and closing at $6.51 for a move of 0.15%.
What's Enzo Biochem, Inc. Upside After Reaching 52-Week High?
The stock of Enzo Biochem, Inc. (NYSE:ENZ) hit a new 52-week high and has $16.36 target or 135.00% above today's $6.96 share price.
Enzo Biochem Releases New Investor Presentation on Corporate Strategy
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today released a new investor presentation that, in light of recently announced approval for the Company's HCV viral load testing by the New York State Department of Health, centers on an ...